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sequential elimination, double-aza-
Michael and Huisgen cycloaddition1. Current literature highlights
1.1. Automated synthesis of a library of triazolated 1,2,5-
thiadiazepane-1,1-dioxides
Automated synthesis offers much promise for the rapid and
largely unattended preparation of compounds for drug discovery
purposes. To date it has been most widely used where the
chemistry is predictable and repetitive such as peptide or polymer
synthesis. However, there have been a number of recent demon-
strations of the power of automated synthesis to prepare single
compounds or small arrays using more diverse and challenging
synthetic chemistry. A recent paper describes an automated
approach to the synthesis of a library of 96 compounds using one
pot sequential elimination, double-aza-Michael reaction and
Huisgen cycloaddition.1
The intermediate 3, prepared from the reaction of a chlorosul-
phonyl chloride (1) with a serine derivative (2), was critical to this
library synthesis. The material was N-alkylated with propargyl
bromide and then following elimination of the hydroxyl, a range
of amines were added in a double Michael reaction. Huisgen cyclo-
addition to the acetylene gave the product 1,2,5-thiadiazepane-
1,1-dioxides (4). The sequence of events could also be reversed,
N-alkylating the key intermediate 3 with a range of alkyl halides
and then using propargylamine in the double Michael addition.
Huisgen cycloaddition gave the alternative isomeric 1,2,5-thia-
diazepane-1,1-dioxides (5).
Using these complementary approaches the 96 library members
were made on a Chemspeed Accelerator (SLT-100) automated
parallel synthesis platform. The crude product solutions were col-
lected and evaporated before being subjected to preparative/mass-
directed HPLC puriﬁcation. A total of 94 from the targeted 96
library members were obtained in sufﬁcient yield (averaging
40%) and exceeding 90% purity. The compounds have been submit-
ted for biological evaluation at the NIH Molecular Library Probe
centre Network MLPCN.
2. A summary of the papers in this month’s issue
2.1. Polymer supported synthesis
No papers this month.http://dx.doi.org/10.1016/j.comche.2012.08.001
E-mail: nterrett@ensemblediscovery.com2.2. Solution-phase synthesis
A three-component sequential process consisting of (1) in situ
formation of carbodiimides by Staudinger reaction, (2) reaction
with 2-(bromomethyl)-3-aryl-2-propenoic acids and (3) ﬁnal
cyclisation of the resulting N-acylurea intermediates has been used
to synthesise a library of N,N0-disubstituted 5-arylidenedihydro-
pyrimidine-2,4-diones under mild conditions.2
1,3,5-Triazepan-2,6-diones are a class of conformationally
restricted heterocycles derived from dipeptides. With the aim to
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tion, three polymer-assisted syntheses, all based on a catch and
release approach, have been evaluated and compared. The method
involving a Hofmann rearrangement of N-Boc dipeptide carboxam-
ides and subsequent trapping of the isocyanate on polymer-sup-
ported N-hydroxysuccinimide (PS-HOSu) was found to be the
most reliable and versatile, allowing rapid access to the 1,3,5-tria-
zepan-2,6-dione skeleton.3
2.3. Scaffolds and synthons for combinatorial libraries
No papers this month.
2.4. Solid-phase supported reagents
Various heterogeneous catalysts have been prepared and
screened for the synthesis of Betti bases in an attempt to reduce
the environmental hazards associated with conventional homoge-
neous Lewis acid systems. It was found that Cu(OTf)2SiO2 cataly-
ses the three-component coupling of aldehyde, 2-naphthol, and
alicyclic amine to generate Betti base with high efﬁciency under
neat conditions without additional co-catalyst or additive in air.4
Polystyrene-supported 2-isobutoxy-1-isobutoxycarbonyl-1,2-
dihydroquinoline (PS-IIDQ), a polymer supported covalent cou-
pling reagent, has successfully been employed for the ﬁrst time
in the synthesis of 8-substituted xanthine derivatives. PS-IIDQ
was observed to be more efﬁcient than IIDQ and polymer-sup-
ported carbodiimide (PS-EDC).5
Solid supported palladium(0) (SS-Pd) has been used to catalyse
the highly chemoselective reduction of nitroarenes to the corre-
sponding anilines under mild reaction conditions. This catalyst
showed high compatibility with various reducing agents (NaBH4,
Et3SiH, and NH2NH2H2O) and a large number of reducible func-
tional groups such as sulphonamide, amide, carboxylic acid, ester,
alcohol, halide, hetero cycle, nitrile, alkene, carbonyl, O-benzyl, and
N-benzyl were tolerated. Most of the reactions were clean and high
yielding and the SS–Pd catalyst could be recycled up to seven runs
without signiﬁcant loss of activity.6
2.5. Novel resins, linkers and techniques
An alkoxyamine linker has been used for the solid-phase syn-
thesis of benzothiazoles. The substrate was anchored by aldoxime
linkage and products were cleaved from the solid-support by
aldoxime–imine exchange coupled with air-oxidation under the
weakly acidic conditions. The tether is highly robust under Mitsun-
obu reaction, nucleophilic substitution reaction, and Pd-catalysed
reaction conditions.7
PEGylated core–shell type resin (PEG-AM SURE) has been devel-
oped by modifying the surface of AM SURE™ resin with diamino
PEG. The conditions for the PEG coupling reaction have been opti-
mised by adjusting PEG chain cross-linking and the amount of free
amino groups to ensure a enough loading level of functional groups
on the resin (>0.30–0.39 mmol NH2/g). The resulting PEG-AM SURE
resin showed better performance than conventional resins during
solid-phase peptide synthesis of JR10-mer and b2m58–69 12-mer.8
2.6. Library applications
4H-Pyrano-[2,3-b]naphthoquinone is a structural motif com-
monly found in natural products manifesting anticancer activities.
As part of a program aimed at structural simpliﬁcation of bioactive
natural products using multicomponent synthetic processes, a
compound library has been developed based on this heterocyclic
scaffold. Several library members displayed low micromolar anti-
proliferative activity and induced apoptosis in human cancer cells,and selected compounds showed promising activity against cancer
cell lines resistant to proapoptotic stimuli, demonstrating their
potential in treating cancers with dismal prognoses.9
Mcl-1, an anti-apoptotic member of the Bcl-2 protein family, is
overexpressed in a broad range of human cancers and plays a crit-
ical role in conferring resistance to chemotherapy. In the course of
screening a natural product-like library of sesquiterpenoid ana-
logues, substituted hexahydronaphthalenes that showed activity
against the Mcl-1/BimBH3 interaction in vitro were identiﬁed. A
small library of analogues have been prepared and their biological
evaluation reported. The most potent inhibitor in the series exhib-
ited an IC50 of 8.3 lM by ELISA and disrupted the interaction be-
tween endogenously expressed Mcl-1 and Bim in cultured MDA-
MB-468 breast cancer cells.10
Synthesis and anticonvulsant activity of new N-Mannich bases
of 3-(2-ﬂuorophenyl)- and 3-(2-bromophenyl)-pyrrolidine-2,5-
diones have been described. Initial anticonvulsant screening was
performed in mice after intraperitoneal administration in the max-
imal electroshock seizure test (MES) and subcutaneous pentylen-
etetrazole seizures test (scPTZ). The in vivo results in mice
showed that majority of compounds were effective in the MES test.
These molecules were more potent and also less neurotoxic than
phenytoin which was used as reference antiepileptic drug.11
The a4b7 integrin is a well-known target for the development
of drugs against various inﬂammatory disease states including
inﬂammatory bowel disease, type 1 diabetes and multiple sclero-
sis. The synthesis of a small library of cell-permeable b7 integrin
inhibitors based on the peptide biotin-R8ERY has been reported,
in which the tyrosine residue has been modiﬁed by using the Suzu-
ki–Miyaura cross-coupling reaction. The synthesised peptidomi-
metics were evaluated in a cell adhesion assay and shown to
inhibit Mn2 + -activated adhesion of mouse TK-1 T cells to mouse
MAdCAM-1.12
A synthetic strategy to access small libraries of triazolylmeth-
oxy chalcones, triazolylmethoxy ﬂavanones and triazolylmethoxy
aminopyrimidines from a common substrate 4-propargyloxy-2-
hydroxy acetophenone using a set of different reactions has been
developed. The chalcones and ﬂavanones were screened against
mycobacterial FAS-II pathway using a recombinant mycobacterial
strain, against which the most potent compound showed 88%
inhibition in bacterial growth and substantial induction of reporter
gene activity at 100 lM concentration.13
Malaria and HIV are among the most important global health
problems of our time and together are responsible for approxi-
mately 3 million deaths annually. In a recent study, the generation
and characterisation of hybrid molecules to target Plasmodium fal-
ciparum and HIV simultaneously for a potential HIV/malaria com-
bination therapy were investigated. Hybrid molecules were
synthesised by the covalent fusion of azidothymidine (AZT) with
dihydroartemisinin (DHA), a tetraoxane or a 4-aminoquinoline
derivative; and the small library was tested for antiviral and anti-
malarial activity.14
New analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenyl-
thio)thymine (HEPT) have been synthesised and evaluated for their
in vitro activities against HIV-1 in MT-4 cell cultures. Chemical
diversity was introduced in four of the six positions of the core
and the inﬂuence of each substituent was studied. This library
was built on the basis of a rational diversity analysis with the
objective of maximising diversity and thus, the activity range with
a minimum number of synthesised compounds.15
In silico screening of a collection of 1584 academic compounds
identiﬁed a small molecule hit for the human adenosine A2A
receptor (pKi = 6.2) containing a novel chromene scaffold. To ex-
plore the structure–activity relationships of this new chemical ser-
ies for adenosine receptors, a focussed library of 43 2H-chromene-
3-carboxamide derivatives has been synthesised and tested in
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A3 receptors.16
The close structural similarity between the two cyclooxygenase
(COXs) isoforms and the absence of selective inhibitors without
side effects continues to stimulate the development of novel ap-
proaches towards selective anti-inﬂammatory drugs. In a recent
study a small library of new indolic compounds involving two
different substitution patterns at the indole scaffold has been
synthesised. In order to establish a relation between the spatial
distribution of known functional groups related with inhibitory
activity, two substitution patterns were explored. From the tested
compounds, one substitution pattern correlated with the highest
inhibitory activity and selectivity, giving 70% COX-2 inhibition at
50 lM, and low COX-1 inhibition (18 ± 9%).17
A library of ﬂavonol analogues has been synthesised and evalu-
ated as potential anticancer agents against a human prostate can-
cer cell line, 22rm1. Several compounds showed potent cancer cell
growth inhibition, comparable to the lead compound and superior
to the naturally occurring ﬂavonols quercetin and ﬁsetin.18References
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